AGL 40.03 Decreased By ▼ -0.18 (-0.45%)
AIRLINK 127.65 Increased By ▲ 0.01 (0.01%)
BOP 6.67 No Change ▼ 0.00 (0%)
CNERGY 4.50 Increased By ▲ 0.05 (1.12%)
DCL 8.72 Decreased By ▼ -0.01 (-0.11%)
DFML 41.19 Increased By ▲ 0.03 (0.07%)
DGKC 86.70 Increased By ▲ 0.59 (0.69%)
FCCL 33.09 Increased By ▲ 0.53 (1.63%)
FFBL 64.10 Decreased By ▼ -0.28 (-0.43%)
FFL 11.72 Increased By ▲ 0.11 (0.95%)
HUBC 112.47 Increased By ▲ 0.01 (0.01%)
HUMNL 14.98 Increased By ▲ 0.17 (1.15%)
KEL 5.15 Increased By ▲ 0.11 (2.18%)
KOSM 7.41 Increased By ▲ 0.05 (0.68%)
MLCF 40.59 Increased By ▲ 0.26 (0.64%)
NBP 61.44 Increased By ▲ 0.36 (0.59%)
OGDC 194.00 Decreased By ▼ -0.18 (-0.09%)
PAEL 27.09 Increased By ▲ 0.18 (0.67%)
PIBTL 7.33 Increased By ▲ 0.05 (0.69%)
PPL 153.61 Increased By ▲ 0.93 (0.61%)
PRL 26.46 Increased By ▲ 0.24 (0.92%)
PTC 16.41 Increased By ▲ 0.27 (1.67%)
SEARL 86.01 Increased By ▲ 0.31 (0.36%)
TELE 7.54 Decreased By ▼ -0.13 (-1.69%)
TOMCL 33.55 Decreased By ▼ -2.92 (-8.01%)
TPLP 8.79 No Change ▼ 0.00 (0%)
TREET 16.81 Decreased By ▼ -0.03 (-0.18%)
TRG 62.50 Decreased By ▼ -0.24 (-0.38%)
UNITY 28.35 Increased By ▲ 0.15 (0.53%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
BR100 10,139 Increased By 53.5 (0.53%)
BR30 31,315 Increased By 145 (0.47%)
KSE100 95,170 Increased By 406.3 (0.43%)
KSE30 29,557 Increased By 147.1 (0.5%)

THE HAGUE: The EU's drug regulator gave the green light for the Pfizer-BioNTech coronavirus vaccine on Monday, and said there was no evidence it would not work against a new strain spreading in Britain.

The European Medicines Agency said the "historic" step paved the way for vaccinations to finally start within days across the 27-nation EU where cases of the disease are surging.

The Amsterdam-based watchdog had moved the decision forward from December 29 under pressure from EU governments, after Britain and the United States gave the green light weeks earlier.

"It is a significant step forward in the fight against this pandemic that is causing suffering and hardship," EMA chief Emer Cooke told an online press conference as she announced the decision.

"This is really a historic scientific achievement, within less than a year a vaccine will have been developed and authorised against this disease."

Following the EMA's recommendation, the European Commission is set to formally sign off within hours on a one-year "conditional marketing authorisation" for the vaccine developed by US giant Pfizer and German firm BioNTech.

"It's a decisive moment in our efforts to deliver safe & effective vaccines to Europeans!" European Commission chief Ursula von der Leyen said on Twitter. "Now we will act fast. I expect a @EU_Commission decision by this evening."

Comments

Comments are closed.